CYMABAY THERAPEUTICS INC filings

SEC filings by CYMABAY THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14Avoro Capital Advisors LLCCymaBay Therapeutics, Inc.16,337,73910.0%EDGAR
SC 13G/A2024-02-14PERCEPTIVE ADVISORS LLCCymaBay Therapeutics, Inc.4,024,4003.5%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPCymaBay Therapeutics, Inc.00.0%EDGAR
SC 13G2024-02-14JANUS HENDERSON GROUP PLCCymaBay Therapeutics, Inc.6,103,7975.4%EDGAR
SC 13G/A2024-02-13TCG Crossover GP I, LLCCymaBay Therapeutics, Inc.00.0%EDGAR
SC 13G2024-02-13VANGUARD GROUP INCCymaBay Therapeutics, Inc.6,306,1495.6%EDGAR
SC 13G2024-01-25BlackRock Inc.CymaBay Therapeutics, Inc.9,610,2398.5%EDGAR
SC 13G2023-09-22RA CAPITAL MANAGEMENT, L.P.CymaBay Therapeutics, Inc.6,940,0006.2%EDGAR
SC 13G2023-09-11ADAGE CAPITAL PARTNERS GP, L.L.C.CymaBay Therapeutics, Inc.3,685,6253.8%EDGAR
SC 13G2023-03-10PERCEPTIVE ADVISORS LLCCymaBay Therapeutics, Inc.5,278,9625.6%EDGAR
SC 13G/A2023-02-14TCG Crossover GP I, LLCCymaBay Therapeutics, Inc.5,905,4006.2%EDGAR
SC 13G/A2023-02-14COMMODORE CAPITAL LPCymaBay Therapeutics, Inc.5,738,5006.8%EDGAR
SC 13G2022-07-08BlackRock Inc.CymaBay Therapeutics, Inc.1,948,0332.3%EDGAR
SC 13G/A2022-02-14COMMODORE CAPITAL LPCymaBay Therapeutics, Inc.5,419,8967.8%EDGAR
SC 13G/A2022-02-14Boxer Capital, LLCCymaBay Therapeutics, Inc.-0.0%EDGAR
SC 13G/A2022-02-11Avoro Capital Advisors LLCCymaBay Therapeutics, Inc.12,800,00014.7%EDGAR
SC 13G/A2022-02-01BlackRock Inc.CymaBay Therapeutics, Inc.5,324,1286.3%EDGAR
SC 13G2021-11-29TCG Crossover Management, LLCCymaBay Therapeutics, Inc.5,905,4007.0%EDGAR
SC 13G2021-07-12COMMODORE CAPITAL LPCymaBay Therapeutics, Inc.3,529,4655.1%EDGAR
SC 13G/A2021-02-16Foresite Capital Fund III, L.P.CymaBay Therapeutics, Inc.1,641,8042.4%EDGAR